EcoDrugPlus

Ensembl ID : ENSCHYG00000017548
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSCHYG00000017417
Gene Symbol: -
Cross references: -
380 Possible Orthologues:

Ensembl ID : ENSCHYG00000016488
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSCHYG00000016436
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Ensembl ID : ENSCHYG00000016315
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSCHYG00000016198
Gene Symbol: -
Cross references: -
118 Possible Orthologues:

Ensembl ID : ENSCHYG00000015851
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSCHYG00000015753
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSCHYG00000009872
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSCHYG00000010576
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSCHYG00000015558
Gene Symbol: -
Cross references: -
339 Possible Orthologues:

Ensembl ID : ENSCHYG00000015219
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).